Ask DrugCentral
Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIYour question
Ask in your own words. Each question is answered independently.
Explore sample questions
Select a question to fill the editor, then ask it or make it your own.
DrugCentral answer
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
About Ask DrugCentral
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
General architecture
- Ask a questionThe browser sends your question to the same-origin Django chat API.
- Retrieve and generateThe API forwards the question to the configured DrugCentral retrieval-augmented generation (RAG) service, which returns an AI-generated answer.
- Explore the answerThe app resolves cited drug-card names and displays the answer with links to drug records.
Using the assistant
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
trenbolone acetate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| steroids not used as glucocorticosteroids | 5636 | 10161-34-9 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
An anabolic steroid used mainly as an anabolic agent in veterinary practice
|
Drug dosage:
None
ADMET properties:
None
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D006728 | Hormones |
| MeSH PA | D045930 | Anabolic Agents |
| CHEBI has role | CHEBI:76924 | plant metabolite |
| CHEBI has role | CHEBI:138015 | endocrine disruptor |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Cattle | To increase rate of weight gain | Indication |
| Cattle | To improve feed efficiency | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Finaplix-H, Finaplix-S | Intervet Inc. | 1 |
| Revalor-G, Revalor-IS, Revalor-S | Intervet Inc. | 2 |
| Revalor-200, Revalor-H, Revalor-IH | Intervet Inc. | 2 |
| SYNOVEX Choice, SYNOVEX PLUS | Zoetis Inc. | 2 |
| Revalor-XH, Revalor-XS | Intervet Inc. | 2 |
| SYNOVEX ONE FEEDLOT, SYNOVEX ONE Grower | Zoetis Inc. | 2 |
| Revalor-XR | Intervet Inc. | 2 |
| Component TE-G, Component TE-G with Tylan, Component TE-ID with Tylan, Component TE-IS, Component TE-IS with Tylan, Component TE-S, Component TE-S with Tylan | Elanco US Inc. | 3 |
| Component T-H with Tylan, Component T-S with Tylan | Elanco US Inc. | 2 |
| Component TE-200 with Tylan, Component TE-H with Tylan, Component TE-IH with Tylan | Elanco US Inc. | 3 |
| Synovex T120, Synovex T40, Synovex T80 | Zoetis Inc. | 2 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Polymerase acidic protein | Enzyme | Kd | 4.04 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| CHEBI:192671 | CHEBI |
| CHEMBL1698011 | ChEMBL_ID |
| DB14660 | DRUGBANK_ID |
| DB11551 | DRUGBANK_ID |
| 117059000 | SNOMEDCT_US |
| 96344003 | SNOMEDCT_US |
| C0076958 | UMLSCUI |
| D014204 | MESH_DESCRIPTOR_UI |
| 10161-33-8 | SECONDARY_CAS_RN |
| D06211 | KEGG_DRUG |
| 66359 | PUBCHEM_CID |
| 25015 | PUBCHEM_CID |
| 005817 | NDDF |
| RUD5Y4SV0S | UNII |
| 2916 | INN_ID |
| 1484277 | RXNORM |
| P53R4420TR | UNII |
| CHEBI:35018 | CHEBI |
| P53R4420TR | INXIGHT DRUGS |
| RUD5Y4SV0S | INXIGHT DRUGS |
Pharmaceutical products:
None